Portal de investigación
INHIBITORS OF THE MUTATED DEHYDROGENASE (MIDH), IVOSIDENIB OR ENASIDENIB, IN COMBINATION WITH AZACITINE (AZA) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Di Nardo, CD
- Stein, AS
- Stein, EM
- Fathi, AT
- Schuh, AC
- Odenike, O
- Kantarjian, HM
- Stone, RM
- Collins, R
- Martinelli, G
- Arnan, M
- Wu, B
- Zhang, V
- Gong, J
- MacBeth, KJ
- Vyas, P
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Montesinos,P,Di,CD,Stein,AS,Stein,EM,Fathi,AT,Schuh,AC,Odenike,O et al. INHIBITORS OF THE MUTATED DEHYDROGENASE (MIDH), IVOSIDENIB OR ENASIDENIB, IN COMBINATION WITH AZACITINE (AZA) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML). 60th National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy. 2018. Granada. VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY:FERRATA STORTI FOUNDATION. 2018 p.p. 25-26.